Metastatic Disease as a Distinct Discipline in Radiation Oncology
Author:
Affiliation:
1. Precision Radiation for Oligometastatic and Metastatic Disease (PROMISE) Program, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2771757/jamaoncology_tsai_2020_vp_200015_1609897976.54614.pdf
Reference6 articles.
1. The oligometastatic state—separating truth from wishful thinking.;Palma;Nat Rev Clin Oncol,2014
2. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.;Palma;Lancet,2019
3. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.;Gomez;Lancet Oncol,2016
4. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: the ORIOLE phase 2 randomized clinical trial.;Phillips;JAMA Oncol,2020
5. Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial.;Nguyen;JAMA Oncol,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases;Frontiers in Oncology;2023-12-05
2. Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis;Radiotherapy and Oncology;2023-10
3. Radiation Therapy at the End of-Life: Quality of Life and Financial Toxicity Considerations;Seminars in Radiation Oncology;2023-04
4. Personalized Palliative and Survivorship Care for Patients With Metastatic Cancer Treated With Radiation Therapy;Anticancer Research;2023-03-27
5. The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease;Seminars in Radiation Oncology;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3